The Placement is being undertaken at A$0.30 per share
Single tranche placement to raise gross proceeds of approximately A$60 million
use - Sales force and marketing infrastructure to support the commercial launch - Sofdra in the USA
Placement Closes today
Sold to sophisticated investors, institutional investors or professional investors - New Zealand, Hong Kong, Singapore and the United Kingdom
Ann: FDA Approves Sofdra, page-170
-
- There are more pages in this discussion • 385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.8¢ |
Change
-0.003(0.69%) |
Mkt cap ! $654.2M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $1.340M | 3.735M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 642004 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 341137 | 14 |
View Market Depth
| Last trade - 15.33pm 16/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |